Form 8-K - Current report:
SEC Accession No. 0001628280-19-014002
Filing Date
2019-11-12
Accepted
2019-11-12 17:15:42
Documents
3
Period of Report
2019-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a2019q38k-earningsrelease.htm 8-K 37561
2 EXHIBIT 99.1 a2019q3-ex991earningsrelea.htm EX-99.1 348850
3 cumberlandpharmaimageaa06.jpg GRAPHIC 37721
  Complete submission text file 0001628280-19-014002.txt   439587
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 191210780
SIC: 2834 Pharmaceutical Preparations